ASRT vs FAST · rev $125.0M vs P/E 43, rev $7.55B
Assertio Therapeutics Inc (ASRT) versus Fastenal Company (FAST) — a side-by-side from cached financials, not a winner call.
Assertio Therapeutics Inc (ASRT) is a drug manufacturers - specialty & generic company listed on US.
Fastenal Company (FAST) is a industrial distribution company listed on US.
Latest reported ASRT revenue for 2024-12-31 was $125.0M. Net income was -$21.6M. Revenue was down 17.8% from 2023-12-31 to 2024-12-31. ASRT currently screens at market cap $151.5M.
Latest reported FAST revenue for 2024-12-31 was $7.55B. Net income was $1.15B. Revenue was up 2.7% from 2023-12-31 to 2024-12-31. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
ASRT currently screens at market cap $151.5M. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
Not investment advice. Open the ASRT and FAST stock pages for the full models.
Not investment advice.